Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
54 hedge funds and large institutions have $150M invested in Akoya BioSciences in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
24% more capital invested
Capital invested by funds: $121M → $150M (+$29.1M)
17% more funds holding
Funds holding: 46 → 54 (+8)
1.69% more ownership
Funds ownership: 32.85% → 34.54% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$3.07M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.71M |
| 3 |
CEI
Clark Estates Inc
New York
|
+$1.79M |
| 4 |
RI
RTW Investments
New York
|
+$1.62M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$2.59M |
| 2 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$2.19M |
| 3 |
Legal & General Group
London,
United Kingdom
|
-$2.01M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.23M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$501K |
AKYA Hedge Fund Activity: Q2 2022 in Review
54 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2022, worth a combined $150M — up 24% from $121M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AKYA positions and 4 closed out — a net gain of 9 holders — while 22 added to existing stakes and 12 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $3.07M. The largest seller was Allspring Global Investments, cutting an estimated $2.59M.
- 54 institutional investors held Akoya BioSciences (AKYA) as of Q2 2022, up from 46 in Q1 2022.
- Funds reported $150M of Akoya BioSciences stock for Q2 2022, up 24% quarter-over-quarter.
- 13 funds opened new Akoya BioSciences positions in Q2 2022 and 4 closed out, a net change of +9 holders.
- The largest Akoya BioSciences buyer in Q2 2022 was Altium Capital Management, an estimated $3.07M added.
- The largest Akoya BioSciences seller in Q2 2022 was Allspring Global Investments, an estimated $2.59M sold.
Based on aggregated 13F filings for Q2 2022.